063160.KS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 14:30):

Stats
今日成交量	13 360.00
平均成交量	18 988.00
市值	132.49B
EPS	KRW0 ( 2024-04-25 )
下一个收益日期	( KRW0 ) 2024-07-26
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	-5.73
ATR14	KRW30.25 (0.13%)

音量相关性

長: -0.18 (neutral)

短: 0.89 (strong)

Signal:(62.565) Same movement expected

CKD Bio Corp. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

CKD Bio Corp. 相关性 - 货币/商品

-0.16
( neutral )

-0.30
( neutral )

0.13
( neutral )

0.11
( neutral )

-0.05
( neutral )

0.21
( neutral )

CKD Bio Corp. 财务报表

Annual	2023
营收:	KRW160.35B
毛利润:	KRW5.01B (3.12 %)
EPS:	KRW-4 409.90

FY	2023
营收:	KRW160.35B
毛利润:	KRW5.01B (3.12 %)
EPS:	KRW-4 409.90

FY	2022
营收:	KRW156.04B
毛利润:	KRW16.79B (10.76 %)
EPS:	KRW-3 044.61

FY	2021
营收:	KRW142.24B
毛利润:	KRW13.31B (9.35 %)
EPS:	KRW-1 215.54

Financial Reports:

No articles found.

CKD Bio Corp.

CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, ß-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The company also provides contract research and development, and manufacturing services for active pharmaceutical ingredients and intermediates, and probiotics. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.